World Health Assembly highlights: avian flu, polio eradication, HIV/AIDS, IPR

4 June 2006

The World Health Assembly, the supreme decision-making body of the World Health Organization, concluded its 59th session on May 27 in a week that began with the death of its Director General Lee Jong-wook (Marketletter May 29). More than 2,200 people from WHO's 192 member states, non-governmental organizations and other observers attended the gathering.

IHR implementation speeded up

Highlights of the Assembly included the agreement to voluntarily implement parts of the International Health Regulations immediately, in particular those which relate to avian influenza and to a potential pandemic of human influenza. The provisions identified for early voluntary compliance include those relating to rapid and transparent notification, support to countries that request it in investigating and controlling outbreaks, and providing essential information including recommendations for control measures. The IHR (2005) were formally adopted at the WHA in 2005 and are to go into effect in 2007.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight